Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histone Deacetylases
Sabnam Parbin, Swayamsiddha Kar, Arunima Shilpi, et al.
Journal of Histochemistry & Cytochemistry (2013) Vol. 62, Iss. 1, pp. 11-33
Open Access | Times Cited: 148

Showing 1-25 of 148 citing articles:

HDACs and HDAC Inhibitors in Cancer Development and Therapy
Yixuan Li, Edward Seto
Cold Spring Harbor Perspectives in Medicine (2016) Vol. 6, Iss. 10, pp. a026831-a026831
Open Access | Times Cited: 1036
Vitamin D and the epigenome
Irfete S. Fetahu, Julia Höbaus, Enikő Kállay
Frontiers in Physiology (2014) Vol. 5
Open Access | Times Cited: 269
Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer
Hanghang Zhang, Somnath Pandey, Meghan Travers, et al.
Cell (2018) Vol. 175, Iss. 5, pp. 1244-1258.e26
Open Access | Times Cited: 202
Inflammaging and Cancer: A Challenge for the Mediterranean Diet
Rita Ostan, Catia Lanzarini, Elisa Pini, et al.
Nutrients (2015) Vol. 7, Iss. 4, pp. 2589-2621
Open Access | Times Cited: 181
The role of sirtuins in cellular homeostasis
Wioleta Kupis, Jan Pałyga, Ewa Tomal, et al.
Journal of Physiology and Biochemistry (2016) Vol. 72, Iss. 3, pp. 371-380
Open Access | Times Cited: 179
Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials
Lourdes Hontecillas‐Prieto, Rocío Flores-Campos, Andrew Silver, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 142
Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective
Vishal Kumar, Satyabrata Kundu, Arti Singh, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 1, pp. 158-178
Open Access | Times Cited: 118
Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review
Kevin Dzobo, Dimakatso Alice Senthebane, Chelene Ganz, et al.
Cells (2020) Vol. 9, Iss. 8, pp. 1896-1896
Open Access | Times Cited: 99
How Does Chirality Determine the Selective Inhibition of Histone Deacetylase 6? A Lesson from Trichostatin A Enantiomers Based on Molecular Dynamics
Yang Zhang, Jun Ying, Jia Jun Hong, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 5, pp. 2467-2480
Closed Access | Times Cited: 88
The application of histone deacetylases inhibitors in glioblastoma
Rui Chen, Mengxian Zhang, Yangmei Zhou, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 84
Differentiation into an Effector Memory Phenotype Potentiates HIV-1 Latency Reversal in CD4+T Cells
Deanna A. Kulpa, Aarthi Talla, Jessica H. Brehm, et al.
Journal of Virology (2019) Vol. 93, Iss. 24
Open Access | Times Cited: 79
Glioblastoma: Current Status, Emerging Targets, and Recent Advances
Amandeep Thakur, Chetna Faujdar, Ram Sharma, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 8596-8685
Open Access | Times Cited: 67
Regulation of the Methylation and Expression Levels of the BMPR2 Gene by SIN3a as a Novel Therapeutic Mechanism in Pulmonary Arterial Hypertension
Malik Bisserier, Prabhu Mathiyalagan, Shihong Zhang, et al.
Circulation (2021) Vol. 144, Iss. 1, pp. 52-73
Open Access | Times Cited: 57
Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option
Martina Korfei, Poornima Mahavadi, Andreas Guenther
Cells (2022) Vol. 11, Iss. 10, pp. 1626-1626
Open Access | Times Cited: 44
Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches
Ashraf A. El‐Shehawy, Alaa Elmetwalli, Ali H. El‐Far, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 27
Emerging therapeutic strategies in cancer therapy by HDAC inhibition as the chemotherapeutic potent and epigenetic regulator
Dipanjan Karati, Swarupananda Mukherjee, Souvik Roy
Medical Oncology (2024) Vol. 41, Iss. 4
Closed Access | Times Cited: 11
Epigenetic Regulation of Innate and Adaptive Immune Cells in Salt-Sensitive Hypertension
Ashley Pitzer Mutchler, Alexandria Porcia Haynes, Mohammad Saleem, et al.
Circulation Research (2025) Vol. 136, Iss. 2, pp. 232-254
Closed Access | Times Cited: 1
Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapy.
Philip Lee, Ben Murphy, Rickey Miller, et al.
PubMed (2015) Vol. 35, Iss. 2, pp. 615-25
Closed Access | Times Cited: 74
Depletion of HDAC1, 7 and 8 by Histone Deacetylase Inhibition Confers Elimination of Pancreatic Cancer Stem Cells in Combination with Gemcitabine
Mao-Hua Cai, Xiaogang Xu, Shili Yan, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 70
Induction of colon and cervical cancer cell death by cinnamic acid derivatives is mediated through the inhibition of Histone Deacetylases (HDAC)
Preethi G. Anantharaju, D. Bharat Reddy, Mahesh A. Padukudru, et al.
PLoS ONE (2017) Vol. 12, Iss. 11, pp. e0186208-e0186208
Open Access | Times Cited: 68
Tumorigenesis as a process of gradual loss of original cell identity and gain of properties of neural precursor/progenitor cells
Ying Cao
Cell & Bioscience (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 67
Epigenetic silencing of genes enhanced by collective role of reactive oxygen species and MAPK signaling downstream ERK/Snail axis: Ectopic application of hydrogen peroxide repress CDH1 gene by enhanced DNA methyltransferase activity in human breast cancer
Nibedita Pradhan, Sabnam Parbin, Swayamsiddha Kar, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2019) Vol. 1865, Iss. 6, pp. 1651-1665
Open Access | Times Cited: 61
Epigenetic Signaling and Crosstalk in Regulation of Gene Expression and Disease Progression
Soumen K. Manna, Jagdish Mishra, Tirthankar Baral, et al.
Epigenomics (2023) Vol. 15, Iss. 14, pp. 723-740
Closed Access | Times Cited: 16
Sodium butyrate ameliorates high glucose-suppressed neuronal mitophagy by restoring PRKN expression via inhibiting the RELA-HDAC8 complex
Ji Hyeon Cho, Chang Woo Chae, Jae Ryong Lim, et al.
Autophagy (2024) Vol. 20, Iss. 7, pp. 1505-1522
Closed Access | Times Cited: 7
Similarity in gene-regulatory networks suggests that cancer cells share characteristics of embryonic neural cells
Zan Zhang, Anhua Lei, Liyang Xu, et al.
Journal of Biological Chemistry (2017) Vol. 292, Iss. 31, pp. 12842-12859
Open Access | Times Cited: 61
Page 1 - Next Page

Scroll to top